SCHEMBL13253269

SCHEMBL13253269

NCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 11/20 0.54
▸ JAK2 O60674 7/20 0.54
▸ JAK3 P52333 4/20 0.54
▸ HDAC1 Q13547 3/20 0.54
▸ JAK1 P23458 3/20 0.54
▸ MAPK8 P45983 3/20 0.54
▸ TYK2 P29597 2/20 0.54
▸ MAPK9 P45984 2/20 0.54
▸ BMPR1B O00238 1/20 0.54
▸ PLK4 O00444 1/20 0.54
▸ CIT O14578 1/20 0.54
▸ GAK O14976 1/20 0.54
▸ OPA1 O60313 1/20 0.54
▸ ROCK2 O75116 1/20 0.54
▸ STK16 O75716 1/20 0.54
▸ PRKD3 O94806 1/20 0.54
▸ CSNK2A2 P19784 1/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ MARK3 P27448 1/20 0.54
▸ BMPR1A P36894 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866288 0.87 JAK2 (0.71) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL30051820 0.87 JAK2 (0.71) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253183 0.82 JAK2 (0.79) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL4386587 0.80 JAK2 (0.67) MAPK10JAK2JAK3JAK1MAPK8
SCHEMBL13253337 0.77 JAK2 (0.72) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253316 0.76 JAK2 (0.69) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253265 0.76 JAK2 (0.65) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253275 0.76 JAK2 (0.81) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253311 0.76 JAK2 (0.68) MAPK10JAK2JAK3HDAC1JAK1
SCHEMBL13253260 0.75 JAK2 (0.80) MAPK10JAK2JAK3HDAC1JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197671-A1 PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF GLAXOSMITHKLINE LLC 2010-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197671-A1 PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF JAK2, JAK1, JAK3 MAPK10 517/4885JAK2 1/4885JAK3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback